# DESCRIPTION

## TECHNICAL FIELD

- introduce invention

## BACKGROUND ART

- define RNA interference
- describe siRNA
- limitations of siRNA
- conventional approaches
- motivate invention

## DISCLOSURE

### Technical Problem

- identify technical problem of gene expression inhibition

### Technical Solution

- provide composition for sustained inhibition of gene expression
- define T7 RNA polymerase
- describe self-amplification of T7 RNA polymerase
- detail plasmid DNA for self-amplification of T7 RNA polymerase
- describe mRNA fragment of T7 RNA polymerase with 5'-cap structure
- synthesize mRNA fragment of T7 RNA polymerase
- describe plasmid DNA for self-amplification of T7 RNA polymerase
- detail gene expression inhibitor
- describe siRNA, shRNA, microRNA, and aptamer
- detail shRNA expression in cytoplasm
- evaluate long-term shRNA expression
- compare with existing nucleus-dependent shRNA expression
- describe target tissue
- define transporter of gene expression inhibitor
- detail liposome transporter
- prepare liposome transporter
- evaluate liposome transporter
- compare with existing siRNA delivery
- evaluate inhibition of target gene expression
- evaluate accumulation in cancer tissue

### Advantageous Effects of the Invention

- summarize advantages of the invention

## DETAILED DESCRIPTION OF THE INVENTION

- describe invention with reference to examples

### Example 1. Design and Preparation of pT7/T7 Polymerase System Capable of Sustained Expression of shRNA in Cytoplasm

- design auto_T7pol plasmid
- prepare DNA template for cytoplasmic shRNA expression
- synthesize 5â€²-capped T7pol mRNA

### Example 2. Preparation of DOPC Liposome Transporter Loaded with Sustained Cytoplasmic Expression System for shRNA

- prepare DOPC liposomes loaded with sustained cytoplasmic expression system

### Example 3. Examination of Biophysicochemical Properties of DOPC Liposome Transporter Loaded with Sustained Cytoplasmic Expression System for shRNA

- examine oligonucleotide loading efficiency
- examine particle size and biocompatibility

### Example 4. Experiment on Sustained Expression of T7 Polymerase Using Modified pT7/T7 Polymerase System

- examine cytoplasmic expression of T7 polymerase
- examine sustained expression of T7 polymerase

### Example 5. Examination of Long-Term Cytoplasmic Expression of shRNAs by Auto_shRFP@LS and their Conversion to siRNAs

- examine sustained expression of shRNAs
- examine conversion of shRNAs to siRNAs

### Example 6. Examination of In Vitro Gene Silencing by Auto shRNA @LS Nanoparticles

- examine gene silencing by qRT-PCR
- examine gene silencing by western blot
- examine gene silencing by flow cytometry
- compare with existing nucleus-dependent shRNA expression system
- examine duration of gene silencing

### Example 7. Examination of Cancer Accumulation Property of Auto_shRNA@LS Nanoparticles in Mouse Xenograft Model

- examine cancer accumulation property

### Example 8. Examination of Gene Silencing of Auto_shRNA@LS Nanoparticles in Mouse Xenograft Model

- prepare mouse xenograft model
- examine gene silencing effect
- conclude scope of invention

